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Interleukin-36 (IL-36) cytokines are IL-1 family members, predominantly expressed by
epithelial cells such as keratinocytes. Significant upregulation of epidermal IL-36け is now a 
recognised characteristic of psoriatic skin inflammation. IL-36 is known to induce
inflammatory responses in dendritic cells, fibroblasts and epithelial cells. Whilst vascular
alterations are a hallmark of psoriatic lesions and dermal endothelial cells are known to play
a critical role in skin inflammation, the effects of IL-36け on endothelial cells have not been 
documented. We report that endothelial cells (EC), including dermal microvascular cells,
express a functionally active IL-36 receptor. Following IL-36け stimulation, ECs show 
increased NF-せB and AP-1 activation and adhesion molecules ICAM-1 and VCAM-1 are 
both upregulated and this is reversed by the presence of the endogenous IL-36 receptor
antagonist (IL-36RA). Furthermore, IL-36け stimulated ECs secrete the proinflammatory 
chemokines IL-8, CCL2(MCP1) and CCL20. Chemotaxis assays showed increased
migration of T cells following IL-36け stimulation of ECs. These findings add another potential 
role for IL-36け in psoriasis immunopathology. Our results suggest IL-36け has a role in the 
dermal vascular compartment, and it could potentially enhance inflammation by activating
ECs and increasing leukocyte migration to the lesion.
